$RVNC Revance Therapeutics, Inc. Insider Trading Week 10/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Revance Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Revance Therapeutics, Inc. in week 10/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2018 | RVNC | Revance Therapeuti ... | GARDNER PHYLLIS | Director | Option Exercise | M | 2.55 | 1,333 | 3,399 | 0 | |
| Mar 16 2018 | RVNC | Revance Therapeuti ... | GARDNER PHYLLIS | Director | Option Exercise | M | 2.55 | 4,000 | 10,200 | 0 | |
| Mar 16 2018 | RVNC | Revance Therapeuti ... | GARDNER PHYLLIS | Director | Sell | S | 31.51 | 5,333 | 168,045 | 3,000 | 8.3 K to 3 K (-64.00 %) |
| Mar 16 2018 | RVNC | Revance Therapeuti ... | GARDNER PHYLLIS | Director | Buy | M | 2.55 | 1,333 | 3,399 | 8,333 | 7 K to 8.3 K (+19.04 %) |
| Mar 16 2018 | RVNC | Revance Therapeuti ... | GARDNER PHYLLIS | Director | Buy | M | 2.55 | 4,000 | 10,200 | 7,000 | 3 K to 7 K (+133.33 %) |
| Mar 16 2018 | RVNC | Revance Therapeuti ... | Vickers Philip J. | Director | Buy | P | 31.20 | 900 | 28,080 | 6,150 | 5.3 K to 6.2 K (+17.14 %) |
| Mar 16 2018 | RVNC | Revance Therapeuti ... | Vickers Philip J. | Director | Buy | P | 31.25 | 2,250 | 70,313 | 5,250 | 3 K to 5.3 K (+75.00 %) |
| Mar 16 2018 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Option Exercise | M | 2.55 | 20,000 | 51,000 | 0 | |
| Mar 16 2018 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 31.43 | 5,452 | 171,348 | 141,875 | 147.3 K to 141.9 K (-3.70 %) |
| Mar 16 2018 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Buy | M | 2.55 | 20,000 | 51,000 | 147,327 | 127.3 K to 147.3 K (+15.71 %) |
| Mar 16 2018 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Payment of Exercise | F | 31.65 | 2,881 | 91,184 | 127,327 | 130.2 K to 127.3 K (-2.21 %) |
| Mar 16 2018 | RVNC | Revance Therapeuti ... | Browne L Daniel | CEO and President | Sell | S | 32.80 | 1,000 | 32,800 | 130,208 | 131.2 K to 130.2 K (-0.76 %) |
| Mar 15 2018 | RVNC | Revance Therapeuti ... | SILVERNAIL LAUREN P | CFO, CBO & Secretar ... | Option Exercise | M | 8.70 | 25,867 | 225,043 | 0 | |
| Mar 15 2018 | RVNC | Revance Therapeuti ... | SILVERNAIL LAUREN P | CFO, CBO & Secretar ... | Payment of Exercise | F | 31.65 | 1,152 | 36,461 | 71,802 | 73 K to 71.8 K (-1.58 %) |
| Mar 15 2018 | RVNC | Revance Therapeuti ... | SILVERNAIL LAUREN P | CFO, CBO & Secretar ... | Sell | S | 34.50 | 25,867 | 892,412 | 72,954 | 98.8 K to 73 K (-26.18 %) |
| Mar 15 2018 | RVNC | Revance Therapeuti ... | SILVERNAIL LAUREN P | CFO, CBO & Secretar ... | Buy | M | 8.70 | 25,867 | 225,043 | 98,821 | 73 K to 98.8 K (+35.46 %) |